Mark Guerin - Jun 10, 2024 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
CFO
Signature
/s/ Mark Guerin
Stock symbol
TRAW
Transactions as of
Jun 10, 2024
Transactions value $
-$1,044
Form type
4
Date filed
6/20/2024, 04:25 PM
Previous filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Options Exercise +5.5K +15.29% 41.5K Jun 10, 2024 Direct F1
transaction TRAW Common Stock Tax liability -$1.04K -2.22K -5.35% $0.47 39.3K Jun 18, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Restricted Stock Units Options Exercise $0 -5.5K -50% $0.00 5.5K Jun 18, 2024 Common Stock 5.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On June 10, 2022 the reporting person was granted 16,500 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary